Ariad Pharmaceuticals Inc fka ARIA

[AmpleKind]

I tend to believe the french study that shows thrombotic SAE being around 7 times higher compared to competitors

Why?????

The authors of the French study quality their conclusions with so many
confounding factors that they undermine their own claims, and yet still
assert the claim. Sort of like: the study is too small, we can't really say
if the SAE's are related to Iclusig, we have heavily pretreated patients whose
problems might be (!!!) related to damage from previous medications, BUT
nevertheless, here's what we found!

So, what's so persuasive about the study?